We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 93

Dueling court cases issued on same day
  • Kilpatrick Townsend & Stockton LLP
  • USA
  • July 24 2014

On Tuesday morning the U.S. Court of Appeals for the District of Columbia Circuit ruled that an IRS rule for a key piece of the 2010 Affordable Care


FTC v. Actavis
  • Kilpatrick Townsend & Stockton LLP
  • USA
  • June 21 2013

On June 17, 2013, the Supreme Court issued an opinion authored by Justice Breyer in FTC v. Actavis, holding that "reverse payment" settlements are


Supreme Court decision to drop on Thursday
  • Kilpatrick Townsend & Stockton LLP
  • USA
  • June 25 2012

This morning the Supreme Court issued its ruling on the constitutionally of Arizona’s new immigration law


FTC v. Phoebe Putney Health System, Inc., et al.
  • Kilpatrick Townsend & Stockton LLP
  • USA
  • February 20 2013

On February 19, 2013, the United States Supreme Court in Federal Trade Commission v. Phoebe Putney Health System, Inc., et al., unanimously rejected


Nondiscrimination rules delayed for insured health plans
  • Kilpatrick Townsend & Stockton LLP
  • USA
  • January 1 2011

The Affordable Care Act imposes, for the first time, nondiscrimination rules on non-grandfathered, insured group health plans similar to those that apply to self-insured plans under Section 105(h) of the Internal Revenue Code (the Code


Medical syringe company finds competitors’ mark a sticking point; pricks its ire
  • Kilpatrick Townsend & Stockton LLP
  • USA
  • August 21 2012

In DuoProSS Meditech Corp. v. Inviro Medical Devices, Ltd., No 2012-1050, 2012 WL 3292920 (Fed. Cir. Aug. 14, 2012), the U.S. Court of Appeals for the Federal Circuit ruled that the Trademark Trial and Appeal Board erred in failing to cancel two trademark registrations for medical syringes designed to be broken so they could not be reused


NLRB sets a heightened standard for employers challenging narrow bargaining units
  • Kilpatrick Townsend & Stockton LLP
  • USA
  • September 21 2011

When a union petitions the National Labor Relations Board to be certified as the bargaining representative for a group of employees, it identifies the group or "bargaining unit" that it seeks to represent


Federal Circuit's en banc decision delineates and defines a written description requirement
  • Kilpatrick Townsend & Stockton LLP
  • USA
  • March 24 2010

On March 22, the Federal Circuit issued its 9-2 en banc decision in Ariad Pharmaceuticals, Inc. v. Eli Lilly and Co., affirming 112, 1 contains a written description requirement that is separate and distinct from the enablement requirement


Reversal based on obviousness potentially impacts patent rights of stem cell technology
  • Kilpatrick Townsend & Stockton LLP
  • USA
  • May 11 2010

In a decision potentially affecting the ability of biotechnology companies and research institutions to obtain and maintain patent rights concerning stem cell technology, the United States Patent and Trademark Office’s Board of Patent Appeals and Interferences (“BPAI”) recently rejected the claims of U.S. Patent Number 7,029,913 (the “‘913 Patent”) directed to human embryonic stem cell lines


Participants sue wellness program
  • Kilpatrick Townsend & Stockton LLP
  • USA
  • February 14 2011

Last week a federal district court in Florida certified a class action against Broward County Florida's health plan